Veteran operator and investor focused on scaling technology and growth-stage businesses, with hands-on experience in fundraising, strategic partnerships and board governance. Chris Chatto brings a blend of executive operating roles and venture investing, advising management teams on go-to-market, capital strategy and exits. Active in private markets and secondary transactions, often sourcing early strategic investors and syndicating rounds.
Veteran operator and investor focused on scaling technology and growth-stage businesses, with hands-on experience in fundraising, strategic partnerships and board governance. Chris Chatto brings a blend of executive operating roles and venture investing, advising management teams on go-to-market, capital strategy and exits. Active in private markets and secondary transactions, often sourcing early strategic investors and syndicating rounds.
Specializes in growth-stage technology investments, combining hands-on operating experience with active venture and secondary market participation to accelerate scale-ups. Employs conviction-led, founder-aligned allocations, prioritizing predictable unit economics, capital-efficient go-to-market strategies and clear exit paths. Prefers concentrated, stage-focused stakes with board or advisory roles to influence execution, uses syndication to manage risk, and targets 3–7 year horizons with disciplined follow-on reserves and outcome-oriented governance.
Specializes in growth-stage technology investments, combining hands-on operating experience with active venture and secondary market participation to accelerate scale-ups. Employs conviction-led, founder-aligned allocations, prioritizing predictable unit economics, capital-efficient go-to-market strategies and clear exit paths. Prefers concentrated, stage-focused stakes with board or advisory roles to influence execution, uses syndication to manage risk, and targets 3–7 year horizons with disciplined follow-on reserves and outcome-oriented governance.
| Trades 2010 | Longs Won 1289/2010 64% | Profit Factor 4.09 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $247,276.27 |
| Average Win $105,594.96 | Best Trade (Aug 14) $3.89M | Sharpe Ratio -17.89 |
| Average Loss -$46,174.2 | Worst Trade (Aug 17) -$3.61M | Z-Score 2.61 (99.09%) |
| Commissions $0 | Avg. Trade Length 10m 2d | Expectancy $51,154.38 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 14,925 | 13,433 | 11,940 | 10,448 | 8,955 | 7,463 | 5,970 | 4,478 | 2,985 | 1,493 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 24,064 | $5.83M | $7.43M | - | $1.6M | 27.41% | -7.354% |
ABBV AbbVie Inc. | 1,118 | $221,334.89 | $280,550.92 | - | $59,216.03 | 26.75% | -2.513% |
ABT Abbott Laboratories | 2,631 | $296,394.85 | $278,096.7 | - | -$18,298.15 | -6.17% | +0.085% |
ACGL Arch Capital Group Ltd | 7,275 | $706,112 | $731,355.75 | - | $25,243.75 | 3.58% | -0.603% |
ACHR Archer Aviation Inc. | 29,750 | $167,012.65 | $138,040 | - | -$28,972.65 | -17.35% | -2.11% |
ACP abrdn Income Credit Strategies Fund | 11,689 | $69,543.57 | $59,146.34 | - | -$10,397.23 | -14.95% | -0.197% |
ACVF American Conservative Values ETF | 44,966 | $2.13M | $2.43M | - | $298,004.57 | 13.99% | +0.549% |
ADI Analog Devices, Inc. | 823 | $264,732.5 | $302,378.43 | - | $37,645.93 | 14.22% | +0.202% |
AER AerCap Holdings N.V. | 4,738 | $649,560.48 | $714,964.15 | - | $65,403.67 | 10.07% | -1.289% |
AFL Aflac Inc. | 10,679 | $896,674.24 | $1.36M | - | $464,684.68 | 51.82% | +0.094% |
AFRM Affirm Holdings, Inc. | 8,515 | $694,398 | $608,907.65 | - | -$85,490.35 | -12.31% | -2.375% |
AGOX Adaptive Alpha Opportunities ETF | 5,982 | $207,355 | $199,559.52 | - | -$7,795.48 | -3.76% | +0.907% |
AMAX Adaptive Hedged Multi-Asset Income ETF | 400,421 | $3.2M | $2.97M | - | -$232,583.85 | -7.27% | +0.135% |
AMD Advanced Micro Devices, Inc. | 2,047 | $558,736.78 | $974,679.03 | - | $415,942.25 | 74.44% | -1.904% |
AMGN Amgen Inc. | 682 | $223,539.08 | $262,679.12 | - | $39,140.04 | 17.51% | -0.64% |
AMZN Amazon.com Inc | 13,642 | $2.58M | $3.7M | - | $1.13M | 43.78% | +15.321% |
ARM Arm Holdings plc American Depositary Receipt | 634 | $224,797 | $151,963.46 | - | -$72,833.54 | -32.4% | -0.766% |
AVGO Broadcom Inc. | 690 | $213,545.26 | $268,603.2 | - | $55,057.94 | 25.78% | +0.371% |
AVK Advent Convertible and Income Fund | 14,547 | $171,062.27 | $180,091.86 | - | $9,029.59 | 5.28% | +0.569% |
AZN AstraZeneca PLC American Depositary Shares | 1,482 | $291,824.21 | $251,406.48 | - | -$40,417.73 | -13.85% | -0.992% |